Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD

Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum sample...

Full description

Saved in:
Bibliographic Details
Published inThorax Vol. 67; no. 12; pp. 1075 - 1080
Main Authors Garcha, Davinder S, Thurston, Sarah J, Patel, Anant R C, Mackay, Alexander J, Goldring, James J P, Donaldson, Gavin C, McHugh, Timothy D, Wedzicha, Jadwiga A
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and British Thoracic Society 01.12.2012
BMJ Publishing Group
BMJ Publishing Group LTD
Subjects
Online AccessGet full text
ISSN0040-6376
1468-3296
1468-3296
DOI10.1136/thoraxjnl-2012-201924

Cover

Loading…
Abstract Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Results Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1%predicted) (r=−0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Conclusions Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.
AbstractList Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Results Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1%predicted) (r=−0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Conclusions Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.
Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. Methods In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Results Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1 %predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Conclusions Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.
BackgroundPrevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.MethodsIn this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.ResultsTypical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean ( plus or minus 1 SEM) load was significantly higher at exacerbation than stable state (108.5( plus or minus 0.3) vs. 107.2( plus or minus 0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV1%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).ConclusionsAirway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.
Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative. In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples. Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032). Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.
Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.BACKGROUNDPrevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological culture. Molecular techniques, such as quantitative PCR (qPCR), may be more informative.In this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.METHODSIn this study, 373 sputum samples from 134 COPD outpatients were assessed for prevalence and load of typical airway bacteria (Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis) by multiplex qPCR, with 176 samples analysed for atypical bacteria. Paired stable and exacerbation typical bacteria data were compared in 52 patients. We compared routine culture with qPCR in 177/373 samples.Typical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).RESULTSTypical bacteria were more prevalent in exacerbation than stable-state paired samples: 30/52 (57.7%) vs. 14/52 (26.9%); p=0.001. In patients who were bacteria-positive at both time points, mean (±1 SEM) load was significantly higher at exacerbation than stable state (108.5(±0.3) vs. 107.2(±0.5) cfu/ml), constituting a 20-fold increase (p=0.011). qPCR was more discriminatory at detecting typical bacteria than microbiological culture (prevalence 59.3% vs. 24.3%; p<0.001). At stable state, higher airway bacterial load correlated with more severe airflow limitation (FEV(1)%predicted) (r=-0.299; p=0.033) and higher inhaled corticosteroid dosage (r=0.382; p=0.008). Mean C-reactive protein was higher in bacterial-associated exacerbations (35.0 Vs 25.1 mg/L; p=0.032).Airway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.CONCLUSIONSAirway bacterial prevalence and load increase at COPD exacerbations and are an aetiological factor. qPCR is more discriminatory than culture, identifying higher airway bacterial prevalence. Exacerbations associated with bacterial detection showed a higher mean C-reactive protein level. In the stable state, airway bacterial load is related to more severe airflow limitation and higher inhaled corticosteroid dosage used.
Author Garcha, Davinder S
Donaldson, Gavin C
Mackay, Alexander J
Thurston, Sarah J
Patel, Anant R C
McHugh, Timothy D
Goldring, James J P
Wedzicha, Jadwiga A
Author_xml – sequence: 1
  givenname: Davinder S
  surname: Garcha
  fullname: Garcha, Davinder S
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
– sequence: 2
  givenname: Sarah J
  surname: Thurston
  fullname: Thurston, Sarah J
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
– sequence: 3
  givenname: Anant R C
  surname: Patel
  fullname: Patel, Anant R C
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
– sequence: 4
  givenname: Alexander J
  surname: Mackay
  fullname: Mackay, Alexander J
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
– sequence: 5
  givenname: James J P
  surname: Goldring
  fullname: Goldring, James J P
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
– sequence: 6
  givenname: Gavin C
  surname: Donaldson
  fullname: Donaldson, Gavin C
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
– sequence: 7
  givenname: Timothy D
  surname: McHugh
  fullname: McHugh, Timothy D
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Clinical Microbiology, University College London, London, UK
– sequence: 8
  givenname: Jadwiga A
  surname: Wedzicha
  fullname: Wedzicha, Jadwiga A
  email: davinder.garcha.09@ucl.ac.uk
  organization: Centre for Respiratory Medicine, University College London, London, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26635404$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22863758$$D View this record in MEDLINE/PubMed
BookMark eNqNkl9v0zAUxS00xLrBRwBZQki8BK6T2HHE0xRgIAarEH8erRvH6VxSp7Pd0X17XNINaS_jxZas3zn3-ugckQM3OkPIUwavGCvE63gxetwu3ZDlwPLdUeflAzJjpZBZkdfigMwASshEUYlDchTCEgAkY9UjcpjnMj1zOSOL5gLdwgRqHV17c4WDcdpQdB0dRuzo2FO0_jde0xZ1NN4i3QTrFvRygy7aiNFeGTpvvu4MQsR2mMRmi9r4FqPpaHM-f_uYPOxxCObJ_j4m39-_-9Z8yM7OTz82J2dZK3IeswpkYaBsq5oXXLKuq4GBFtDpjum2gh4q7AQvhOi50XVdlr2UrGKIumesx-KYvJx813683JgQ1coGbYYBnRk3QTHOWZokgN-PJl_JOeQioc_voMtx4136iGKVZDIXKf9EPdtTm3ZlOrX2doX-Wt2knYAXewCDxqH36LQN_zghCl5Cmbg3E6f9GII3vdJ_kx5d9GgHxUDtOqBuO6B2HVBTB5Ka31HfDLhPl006G6LZ3orQ_1KiSvurLz8axT-dznn5-adqEg8T366W_zniD5VR1PI
CODEN THORA7
CitedBy_id crossref_primary_10_1016_j_pupt_2014_05_002
crossref_primary_10_1016_j_spinee_2015_11_021
crossref_primary_10_1016_S0992_5945_12_71051_6
crossref_primary_10_1136_thoraxjnl_2016_209023
crossref_primary_10_1111_resp_13722
crossref_primary_10_1183_09031936_00041914
crossref_primary_10_12968_pnur_2014_25_4_180
crossref_primary_10_1111_cea_12809
crossref_primary_10_1152_ajplung_00330_2013
crossref_primary_10_1164_rccm_201910_2047ED
crossref_primary_10_1016_j_ajpath_2019_05_012
crossref_primary_10_1183_09031936_00020015
crossref_primary_10_1093_cid_ciu820
crossref_primary_10_1016_j_med_2022_05_013
crossref_primary_10_1186_s12967_021_02788_4
crossref_primary_10_1080_07853890_2020_1831050
crossref_primary_10_1186_2213_0802_1_13
crossref_primary_10_1093_femsre_fuy045
crossref_primary_10_1016_j_rmr_2017_03_005
crossref_primary_10_1038_s41385_022_00541_8
crossref_primary_10_17925_USPRD_2020_5_1_18
crossref_primary_10_1136_thoraxjnl_2015_207194
crossref_primary_10_2147_COPD_S247130
crossref_primary_10_1007_s15010_019_01350_1
crossref_primary_10_1016_j_arbr_2020_08_006
crossref_primary_10_1136_bmjopen_2020_043014
crossref_primary_10_3390_biomedicines9101337
crossref_primary_10_1016_j_nhtm_2015_09_002
crossref_primary_10_3389_fmicb_2021_781797
crossref_primary_10_1111_resp_13032
crossref_primary_10_1164_rccm_201412_2269OC
crossref_primary_10_1183_09031936_00191513
crossref_primary_10_3390_pharmaceutics13020177
crossref_primary_10_1136_bmjresp_2022_001335
crossref_primary_10_1016_j_vaccine_2019_07_100
crossref_primary_10_15172_pneu_2015_6_520
crossref_primary_10_1136_thoraxjnl_2019_214168
crossref_primary_10_1183_23120541_00200_2020
crossref_primary_10_3310_hta24150
crossref_primary_10_1517_14740338_2015_1057494
crossref_primary_10_1097_BRS_0000000000001389
crossref_primary_10_1080_1040841X_2017_1329274
crossref_primary_10_1016_S2213_2600_12_70063_2
crossref_primary_10_3390_vaccines9030261
crossref_primary_10_1038_mi_2013_77
crossref_primary_10_1183_23120541_00027_2016
crossref_primary_10_1159_000507228
crossref_primary_10_1016_j_jacig_2023_100194
crossref_primary_10_1080_02770903_2020_1857395
crossref_primary_10_1136_bmjresp_2021_001067
crossref_primary_10_1080_23744235_2022_2092648
crossref_primary_10_1038_cti_2017_6
crossref_primary_10_1183_13993003_00361_2015
crossref_primary_10_1164_rccm_202302_0222OC
crossref_primary_10_1016_j_jaip_2017_05_024
crossref_primary_10_1164_rccm_202109_2024ED
crossref_primary_10_1007_s15010_015_0833_3
crossref_primary_10_1183_20734735_0099_2024
crossref_primary_10_3390_biomedicines10102611
crossref_primary_10_1016_S2213_2600_13_70211_X
crossref_primary_10_1111_crj_12671
crossref_primary_10_1016_j_ccm_2013_09_009
crossref_primary_10_1183_09031936_00092214
crossref_primary_10_3389_fphys_2017_00115
crossref_primary_10_1097_CM9_0000000000000677
crossref_primary_10_1186_s12931_014_0114_1
crossref_primary_10_5897_JMPR2015_5910
crossref_primary_10_1002_cdt3_66
crossref_primary_10_1136_bmjopen_2013_004546
crossref_primary_10_1152_ajplung_00253_2019
crossref_primary_10_3390_ijms21093044
crossref_primary_10_4104_pcrj_2013_00074
crossref_primary_10_1186_s13063_017_2144_8
crossref_primary_10_2147_COPD_S330817
crossref_primary_10_3389_fmicb_2022_1098133
crossref_primary_10_1016_j_rmed_2024_107692
crossref_primary_10_1016_j_rmed_2025_108025
crossref_primary_10_1186_s43162_021_00094_5
crossref_primary_10_1097_MCP_0b013e32835cfff5
crossref_primary_10_1016_j_eclinm_2020_100427
crossref_primary_10_1164_rccm_201712_2506OC
crossref_primary_10_1186_s12931_021_01653_8
crossref_primary_10_2147_COPD_S371958
crossref_primary_10_1177_1479972316643698
crossref_primary_10_1186_1741_7015_11_181
crossref_primary_10_1513_AnnalsATS_201310_350OC
crossref_primary_10_1016_j_rmed_2015_05_020
crossref_primary_10_2174_1573398X14666181018101021
crossref_primary_10_1016_j_ccm_2013_09_012
crossref_primary_10_1016_j_jaci_2020_02_040
crossref_primary_10_1038_nrd4025
crossref_primary_10_1038_s41598_021_89881_2
crossref_primary_10_1586_17476348_2016_1151789
crossref_primary_10_1371_journal_pone_0149095
crossref_primary_10_4104_pcrj_2013_00048
crossref_primary_10_3390_biomedicines10081949
crossref_primary_10_1186_s12931_017_0559_0
crossref_primary_10_1371_journal_pone_0135199
crossref_primary_10_1016_j_rmed_2024_107586
crossref_primary_10_1111_all_14058
crossref_primary_10_1590_S1806_37132013000300001
crossref_primary_10_1016_j_arbres_2020_04_023
crossref_primary_10_1183_16000617_0084_2023
crossref_primary_10_3389_fvets_2020_608901
crossref_primary_10_1183_09031936_00223113
crossref_primary_10_1183_13993003_02273_2017
crossref_primary_10_1183_13993003_00451_2017
crossref_primary_10_1183_13993003_00328_2018
crossref_primary_10_2147_COPD_S301622
crossref_primary_10_2147_COPD_S405310
crossref_primary_10_1111_resp_12709
crossref_primary_10_1111_ijcp_12535
crossref_primary_10_1183_23120541_00057_2022
crossref_primary_10_1186_s12931_017_0570_5
crossref_primary_10_12677_ACM_2022_1271003
crossref_primary_10_1177_1753465816630208
crossref_primary_10_1164_rccm_201306_1170OC
crossref_primary_10_1183_16000617_0199_2020
crossref_primary_10_1186_cc13148
crossref_primary_10_1097_MCP_0000000000000154
crossref_primary_10_1177_2051013617691041
crossref_primary_10_1007_s11908_014_0444_7
crossref_primary_10_1183_13993003_01225_2018
crossref_primary_10_1378_chest_14_0764
crossref_primary_10_1371_journal_pone_0177931
crossref_primary_10_1111_resp_12734
crossref_primary_10_1513_AnnalsATS_201307_212MG
crossref_primary_10_1016_j_canlet_2017_11_036
crossref_primary_10_1016_j_rmed_2019_08_012
crossref_primary_10_1038_mi_2014_95
crossref_primary_10_1080_14740338_2018_1448786
crossref_primary_10_1155_2018_2349045
crossref_primary_10_3390_biomedicines9101312
crossref_primary_10_1111_crj_13286
crossref_primary_10_1186_s12890_017_0384_8
crossref_primary_10_4046_trd_2018_0030
crossref_primary_10_1016_S2213_2600_14_70169_9
crossref_primary_10_1016_j_cbi_2019_108732
crossref_primary_10_1183_09031936_00005415
crossref_primary_10_3390_biom12101481
crossref_primary_10_3390_ijms24044086
crossref_primary_10_3389_fmicb_2022_818281
crossref_primary_10_1007_s10875_013_9942_x
crossref_primary_10_1186_s12931_020_01552_4
crossref_primary_10_1371_journal_pone_0165553
crossref_primary_10_1183_23120541_00595_2023
crossref_primary_10_1016_j_jtbi_2014_04_010
crossref_primary_10_1183_13993003_01582_2017
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
2014 INIST-CNRS
Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: 2014 INIST-CNRS
– notice: Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
BTHHO
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7QL
C1K
DOI 10.1136/thoraxjnl-2012-201924
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
BMJ Journals
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
BMJ Journals
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitleList
ProQuest One Academic Middle East (New)

Bacteriology Abstracts (Microbiology B)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3296
EndPage 1080
ExternalDocumentID 4027206811
22863758
26635404
10_1136_thoraxjnl_2012_201924
ark_67375_NVC_5KGP54MW_C
thoraxjnl
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations London
United Kingdom--UK
GeographicLocations_xml – name: London
– name: United Kingdom--UK
GrantInformation_xml – fundername: Medical Research Council
  grantid: G0902006
– fundername: Medical Research Council
  grantid: G0800570
GroupedDBID ---
.55
.GJ
.VT
08G
0R~
123
18M
29Q
2WC
354
39C
3O-
4.4
40O
53G
5RE
5VS
6PF
7X7
7~S
88E
8F7
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAYEP
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADZCM
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
E3Z
EBS
EJD
F5P
FEDTE
FYUFA
GX1
H13
HAJ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IH2
IHR
IOF
ITC
J5H
KQ8
L7B
M1P
N4W
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
VVN
W8F
WH7
X7M
YFH
YOC
YQY
ZCG
ZGI
3V.
BSCLL
RHF
AAYXX
ACQHZ
ADGHP
AERUA
CITATION
PHGZM
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
7QL
C1K
ID FETCH-LOGICAL-b625t-7083e04b7953581dd9010c60dcd1cb70f07ad65366f5ec9944f88171aacf11fa3
IEDL.DBID 7X7
ISSN 0040-6376
1468-3296
IngestDate Thu Jul 10 21:56:18 EDT 2025
Mon Jul 21 11:07:28 EDT 2025
Fri Jul 25 06:17:43 EDT 2025
Mon Jul 21 05:50:40 EDT 2025
Mon Jul 21 09:15:27 EDT 2025
Tue Jul 01 02:00:25 EDT 2025
Thu Apr 24 22:57:50 EDT 2025
Wed Oct 30 09:48:00 EDT 2024
Thu Apr 24 23:02:51 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Lung disease
Load
Prevalence
Respiratory disease
Change
Polymerase chain reaction
Respiratory tract
Chronic
Bronchus disease
Anesthesia
Bacteria
Chronic obstructive pulmonary disease
Circulatory system
Obstructive pulmonary disease
Molecular biology
Cardiology
Quantitative analysis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b625t-7083e04b7953581dd9010c60dcd1cb70f07ad65366f5ec9944f88171aacf11fa3
Notes local:thoraxjnl;67/12/1075
PMID:22863758
ark:/67375/NVC-5KGP54MW-C
istex:F4B128648B7CAA97FB48D2B9A79E68EDCB68C9D6
href:thoraxjnl-67-1075.pdf
ArticleID:thoraxjnl-2012-201924
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://thorax.bmj.com/content/thoraxjnl/67/12/1075.full.pdf
PMID 22863758
PQID 1781826201
PQPubID 2041050
PageCount 6
ParticipantIDs proquest_miscellaneous_1551625605
proquest_miscellaneous_1171855026
proquest_journals_1781826201
pubmed_primary_22863758
pascalfrancis_primary_26635404
crossref_citationtrail_10_1136_thoraxjnl_2012_201924
crossref_primary_10_1136_thoraxjnl_2012_201924
istex_primary_ark_67375_NVC_5KGP54MW_C
bmj_primary_10_1136_thoraxjnl_2012_201924
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-12-01
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: 2012-12-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Thorax
PublicationTitleAlternate Thorax
PublicationYear 2012
Publisher BMJ Publishing Group Ltd and British Thoracic Society
BMJ Publishing Group
BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group Ltd and British Thoracic Society
– name: BMJ Publishing Group
– name: BMJ Publishing Group LTD
References Wedzicha, Seemungal 2007; 370
Taylor, Finney-Hayward, Quint 2010; 35
Diederen, van der Valk, Kluytmans 2007; 30
Abdeldaim, Strålin, Olcén 2008; 60
Mathers, Loncar 2006; 3
Wilkinson, Patel, Wilks 2003; 167
Lieberman, Lieberman, Shmarkov 2002; 19
Lieberman, Ben-Yaakov, Lazarovich 2001; 20
Monso, Ruiz, Rosell 1995; 152
Daniels, Schoorl, Snijders 2010; 138
Erb-Downward, Thompson, Han 2011; 6
Wedzicha, Calverley, Seemungal 2008; 177
Larsen, Steen-Jensen, Laursen 2012; 7
Murphy, Brauer, Schiffmacher 2004; 170
Wilkinson, Hurst, Perera 2006; 129
Sethi, Evans, Grant 2002; 347
Rosell, Monsó, Soler 2005; 165
Patel, Seemungal, Wilks 2002; 57
Seemungal, Donaldson, Paul 1998; 157
Salcedo, Cid 2011; 157
Hilty, Burke, Pedro 2010; 5
Welti, Jaton, Altwegg 2003; 45
Papi, Bellettato, Braccioni 2006; 173
Nolan, Hands, Ogunkolade 2006; 351
Hurst, Donaldson, Perera 2006; 174
Miravitlles, Espinosa, Fernández-Laso 1999; 116
Rabe, Hurd, Anzueto 2007; 176
White, Gompertz, Bayley 2003; 58
Calverley, Anderson, Celli 2007; 356
Calverley, Stockley, Seemungal 2011; 139
Huang, Kim, Cox 2010; 14
Hill, Campbell, Hill 2000; 109
Greiner, Day, Altwegg 2003; 41
Curran, Coyle, McManus 2007; 50
References_xml – volume: 30
  start-page: 240
  year: 2007
  article-title: The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease
  publication-title: Eur Respir J
– volume: 35
  start-page: 1039
  year: 2010
  article-title: Defective macrophage phagocytosis of bacteria in COPD
  publication-title: Eur Respir J
– volume: 109
  start-page: 288
  year: 2000
  article-title: Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis
  publication-title: Am J Med
– volume: 174
  start-page: 867
  year: 2006
  article-title: Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease
  publication-title: Am J Respir Crit Care Med
– volume: 116
  start-page: 40
  year: 1999
  article-title: Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD*
  publication-title: Chest
– volume: 45
  start-page: 85
  year: 2003
  article-title: Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions
  publication-title: Diagn Microbiol Infect Dis
– volume: 176
  start-page: 532
  year: 2007
  article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
  publication-title: Am J Respir Crit Care Med
– volume: 173
  start-page: 1114
  year: 2006
  article-title: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations
  publication-title: Am J Respir Crit Care Med
– volume: 170
  start-page: 266
  year: 2004
  article-title: Persistent colonization by haemophilus influenzae in chronic obstructive pulmonary disease
  publication-title: Am J Respir Crit Care Med
– volume: 177
  start-page: 19
  year: 2008
  article-title: The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
  publication-title: Am J Respir Crit Care Med
– volume: 57
  start-page: 759
  year: 2002
  article-title: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations
  publication-title: Thorax
– volume: 370
  start-page: 786
  year: 2007
  article-title: COPD exacerbations: defining their cause and prevention
  publication-title: Lancet
– volume: 138
  start-page: 1108
  year: 2010
  article-title: Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD
  publication-title: Chest
– volume: 3
  start-page: e442
  year: 2006
  article-title: Projections of global mortality and burden of disease from 2002 to 2030
  publication-title: PLoS Med
– volume: 19
  start-page: 392
  year: 2002
  article-title: Serological evidence of Legionella species infection in acute exacerbation of COPD
  publication-title: Eur Respir J
– volume: 157
  start-page: 1418
  year: 1998
  article-title: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
  publication-title: Am J Respir Crit Care Med
– volume: 7
  start-page: e31976
  year: 2012
  article-title: Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota
  publication-title: PLoS One
– volume: 167
  start-page: 1090
  year: 2003
  article-title: Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease
  publication-title: Am J Respir Crit Care Med
– volume: 351
  start-page: 308
  year: 2006
  article-title: SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations
  publication-title: Anal Biochem
– volume: 20
  start-page: 698
  year: 2001
  article-title: Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations
  publication-title: Eur J Clin Microbiol Infect Dis
– volume: 50
  start-page: 112
  year: 2007
  article-title: Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease
  publication-title: FEMS Immunol Med Microbiol
– volume: 60
  start-page: 143
  year: 2008
  article-title: Toward a quantitative DNA-based definition of pneumococcal pneumonia: a comparison of Streptococcus pneumoniae target genes, with special reference to the Spn9802 fragment
  publication-title: Diagn Microbiol Infect Dis
– volume: 152
  start-page: 1316
  year: 1995
  article-title: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush
  publication-title: Am J Respir Crit Care Med
– volume: 6
  start-page: e16384
  year: 2011
  article-title: Analysis of the lung microbiome in the “Healthy” Smoker and in COPD
  publication-title: PLoS One
– volume: 5
  start-page: e8578
  year: 2010
  article-title: Disordered microbial communities in asthmatic airways
  publication-title: PLoS One
– volume: 165
  start-page: 891
  year: 2005
  article-title: Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease
  publication-title: Arch Intern Med
– volume: 129
  start-page: 317
  year: 2006
  article-title: Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD*
  publication-title: Chest
– volume: 58
  start-page: 680
  year: 2003
  article-title: Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis
  publication-title: Thorax
– volume: 157
  start-page: 1
  year: 2011
  article-title: Nontypable Haemophilus influenzae: an intracellular phase within epithelial cells might contribute to persistence
  publication-title: Microbiology
– volume: 347
  start-page: 465
  year: 2002
  article-title: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease
  publication-title: N Engl J Med
– volume: 139
  start-page: 505
  year: 2011
  article-title: Reported pneumonia in patients with COPD: findings from the INSPIRE study
  publication-title: Chest
– volume: 41
  start-page: 1386
  year: 2003
  article-title: Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR
  publication-title: J Clin Microbiol
– volume: 356
  start-page: 775
  year: 2007
  article-title: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
  publication-title: N Engl J Med
– volume: 14
  start-page: 9
  year: 2010
  article-title: A Persistent and Diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations
  publication-title: OMICS
SSID ssj0008117
Score 2.4867039
Snippet Background Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using...
Prevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using microbiological...
BackgroundPrevalence and load of airway bacteria in stable and exacerbated chronic obstructive pulmonary disease (COPD) has been previously studied using...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
bmj
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1075
SubjectTerms Aged
Analysis of Variance
Bacteria
bacterial load
Batch processing
Biological and medical sciences
Cardiology. Vascular system
Chi-Square Distribution
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, asthma
colonisation
COPD
Dyspnea
exacerbations
Female
Haemophilus influenzae
Haemophilus influenzae - isolation & purification
Humans
Inflammation
Linear Models
London
Male
Medical sciences
Moraxella catarrhalis
Moraxella catarrhalis - isolation & purification
Mortality
Pneumology
Polymerase Chain Reaction - methods
Prevalence
Proteins
Pulmonary Disease, Chronic Obstructive - microbiology
Pulmonary Disease, Chronic Obstructive - physiopathology
quantitative PCR
Respiratory Function Tests
Sputum - microbiology
Staphylococcus infections
Steroids
Streptococcus pneumoniae
Streptococcus pneumoniae - isolation & purification
Title Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
URI https://thorax.bmj.com/content/67/12/1075.full
https://api.istex.fr/ark:/67375/NVC-5KGP54MW-C/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/22863758
https://www.proquest.com/docview/1781826201
https://www.proquest.com/docview/1171855026
https://www.proquest.com/docview/1551625605
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbYKiFeEPcFRmUkhMRDWJw4jv2EIOwiUEs1Meib5fgytnVJ17Si_Ht8kjTTHhi8RIpiO9a52N-xzwWh1zY2PKPchY5ZEVLj10HBDA0T6yKhSSFcDPHOozE7OqGfp-m0O3CrO7fKzZrYLNSm0nBGvkcyDlDY71fv51chVI2C29WuhMYWGkDqMjC-smlvcEUQRLnxmmNek7oIHpKwveVPT-H1eTnzYkJieAgIet8qLs9v7FADIPYaPCZV7Ynm2moXf4ejzbZ08ADd7_Ak_tAKwEN0x5aP0N1Rd2P-GJ224QM1PivxfAG5vUGVsSoNnlXK4Mphdbb4pX7jos3brDC4wp_iq5UqmwA0vxziSX4MA3gkWczaznattOeIR6oG518nn56gk4P9b_lR2BVXCAtv8izDzGMvG9EiEymkQDMG_DQ0i4w2RBdZ5KJMGZYmjLnUaiEodZyTjCilHSFOJU_RdlmVdgdhxgthuWXWoxMaGS6cEpQnkbAqZloXAXrrySrnbfoM2ZgdCZM9CySwQLYsCBDdEF_qLks5FMuY_avbu77bf_7nTcPZvrVaXICPW5bK8fdcpl8OJykd_ZB5gIY3WN93iAGr0ciPtLuRBdnpfy2vpTVAr_rPXnPhOkaVtlrVkGadQDq5mN3SBu4xAZWmAXrWytn1BGLuhTrlz2-fwAt0rxHxxgVnF20vFyv70gOpZTFstGWIBh_3x5Nj_3Y4JX8AvC8bsg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JbxMxFLa6SMAFsRMoxUiAxGHoLB6PfUAIpZSUNCFCbcnNeMZ2aQmTNIua_il-I-_NVvVA4dLLXMbPY_l7fv48fgshL21oRMKE8xy30mMG7KDkhnmRdb7MglS6EOOde33eOWCfh_FwhfyuY2HQrbK2iYWhNuMM_5FvBYlAKgz71fvJqYdVo_B2tS6hUapF156fwZFt9m53G_B9FYY7H_fbHa-qKuClwPXnXgKkw_osTWSMub-MQQeFjPsmM0GWJr7zE214HHHuYptJyZgTIkgCrTMXBE5H0O8qWYeN10cXwmTYHPB8DNqsvfQ4rNwqYiiI-Nb8ByC6PMlHoJZBiA-JQfar6a-TSzviOoK7RA9NPQOQXFld4-_0t9gGd-6Q2xV_pR9KhbtLVmx-j9zoVTf098lRGa4wo8c5nUwxlziaDqpzQ0djbejYUX08PdPnNC3zRGuKrvdH9HSh8yLgDcwvHbS_YgfAXNNRKWyXOgMNAGZsaPvLYPsBObiWaX9I1vJxbh8TykUqrbDcAhtivhHSaclE5EurQ55laYu8gWlVkzJdhyqOORFXDQQKIVAlBC3C6slXWZUVHYtzjP4l9rYR-8_vvC6QbVrr6U_0qUti1T9sq7j7aRCz3jfVbpHNS9A3AiFyQ-ZDTxu1LqjK3szUxepokRfNa7AUeP2jcztezDCte4Dp60J-RRu8N0UWHLfIo1LPLgYQClDqWDy5egDPyc3Ofm9P7e32u0_JrULdC_efDbI2ny7sMyBx83SzWDmUfL_upfoHfhxVYA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JbxMxFLa6SBUXxE6gFCMBEochs3g84wNCKCG0hJQIUZqb8XgpLWGSZlHTv8av473Zqh4oXHqZy9gey997z5_HbyHkuQ1NmrDUeY5b4TEDdlBww7zIOl_oIBMuxHjnwT7fPWAfR_FojfyuY2HQrbK2iYWhNhON_8jbQZIiFYb9qu0qt4hht_d2euphBSm8aa3LaZQi0rfnZ3B8m7_Z6wLWL8Kw9_5rZ9erKgx4GfD-hZcAAbE-yxIRYx4wY9BZQXPfaBPoLPGdnyjD44hzF1stBGMuTYMkUEq7IHAqgnHXyWYSwbYJupSMmsOejwGctcceBy2uooeCiLcXPwDd1Uk-BhENQnwIDLhfz36dXNodNxHoFXprqjkA5spKG3-nwsWW2LtFblZclr4rhe82WbP5HbI1qG7r75KjMnRhTo9zOp1hXnE0I1Tlho4nytCJo-p4dqbOaVbmjFYU3fCP6OlS5UXwG5hiOux8wQGAxWbjsrNdKQ3SACzZ0M7nYfceObiWZb9PNvJJbh8SytNM2NRyC8yI-SYVTgmWRr6wKuRaZy3yCpZVTsvUHbI48kRcNhBIhECWELQIqxdf6ipDOhbqGP-r2-um239-52WBbNNazX6if10Sy_1vHRn3PwxjNjiUnRbZuQR90yFEnsh8GGm7lgVZ2Z65vNCUFnnWvAargVdBKreT5RxTvAeYyi7kV7TBO1RkxHGLPCjl7GICYQpCHaePrp7AU7IFSio_7e33H5MbhbQXnkDbZGMxW9onwOcW2U6hOJR8v25N_QOexVmW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+prevalence+and+load+of+airway+bacteria+using+quantitative+PCR+in+stable+and+exacerbated+COPD&rft.jtitle=Thorax&rft.au=Garcha%2C+Davinder+S&rft.au=Thurston%2C+Sarah+J&rft.au=Patel%2C+Anant+R+C&rft.au=Mackay%2C+Alexander+J&rft.date=2012-12-01&rft.eissn=1468-3296&rft.volume=67&rft.issue=12&rft.spage=1075&rft_id=info:doi/10.1136%2Fthoraxjnl-2012-201924&rft_id=info%3Apmid%2F22863758&rft.externalDocID=22863758
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-6376&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-6376&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-6376&client=summon